Ky. Rev. Stat. § 215.531

Current through Acts Received April 24, 2024
Section 215.531 - Drug susceptibility tests on initial isolates from patients with active tuberculosis

Every physician shall order drug susceptibility tests on initial isolates from all patients with active tuberculosis to confirm the anticipated effectiveness of chemotherapy. If the patient continues to produce culture positive results following three (3) months of treatment, the drug susceptibility tests shall be repeated.

KRS 215.531

Effective:7/15/1996
Created 1996, Ky. Acts ch. 33, sec. 2, effective7/15/1996.